Droxidopa in Treating Patients With Neurogenic Hypotension
Please note that the continuation study can be found at http://clinicaltrials.gov/show/NCT00633880.
RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from a lying down to a standing position or after eating a meal. It causes one to feel dizzy, light headed, and weak. Neurogenic hypotension is caused by a problem in the part of the nervous system that controls such functions as heart rate and blood pressure. Droxidopa, a drug that may increase blood pressure, may be an effective treatment for neurogenic hypotension.
PURPOSE: Clinical trial to study the effectiveness of droxidopa in treating patients who have neurogenic hypotension.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Study of Droxidopa in Patients With Neurologic Hypotension|
|Study Start Date:||March 1999|
|Study Completion Date:||March 2006|
|Primary Completion Date:||March 2006 (Final data collection date for primary outcome measure)|
Patients receive escalating doses of droxidopa or placebo for 7-14 days. Patients undergo blood pressure measurements hourly in both supine and standing positions.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004478
|United States, New York|
|New York University School of Medicine|
|New York, New York, United States, 10016|
|Study Chair:||Horacio Kaufmann, MD||New York University School of Medicine|